NPR

At $2.1 Million, New Gene Therapy Is The Most Expensive Drug Ever

The Food and Drug Administration approved a new gene therapy for a rare but devastating genetic disorder. The drugmaker says the cost is worth it because it's a one-time treatment that saves lives.
Zolgensma, a new drug approved by the FDA Friday, costs more than $2 million.

The federal Food and Drug Administration has approved a gene therapy for a rare childhood disorder that is now the most expensive drug on the market. It costs $2.125 million per patient.

But for those patients lucky enough to get it, it appears it can save their lives with a one-time treatment.

Three-year-old Donovan Weisgarber is one of those patients. When he was born he seemed perfectly healthy. But within weeks, it became clear something was terribly wrong.

"It was about when he was about one month old that when

You’re reading a preview, subscribe to read more.

More from NPR

NPR2 min readAmerican Government
Biden Is Giving $6 Billion To Micron For A Semiconductor Project In Upstate New York
The Micron project comes after the White House has announced massive investments for Intel, TSMC and Samsung in recent weeks using funds from the 2022 CHIPS and Science Act.
NPR5 min readFinance & Money Management
Housing Experts Say There Just Aren't Enough Homes In The U.S.
The United States is millions of homes short of demand, and lacks enough affordable housing units. And many Americans feel like housing costs are eating up too much of their take-home pay.
NPR2 min readInternational Relations
World Central Kitchen Workers Killed In Israeli Strikes Will Be Honored At Memorial
The aid workers were killed April 1 when a succession of Israeli armed drones ripped through vehicles in their convoy as they left one of World Central Kitchen's warehouses on a food delivery mission.

Related Books & Audiobooks